SWOG clinical trial number
SWOG-9216 (INT-0131) (NCIC-CTG-BR.8)

A Randomized Phase III Study of CODE Plus Thoracic Irradiation Versus Alternating CAV and EP for Extensive Stage Small Cell Lung Cancer, (NCIC CTG)

Closed
Phase
Published
Abbreviated Title
A Randomized Phase III Study of CODE Plus Thoracic Irradiation Versus Alternating CAV and EP for Extensive Stage Small Cell Lung Cancer, (NCIC CTG)
Activated
12/15/1992
Closed
04/26/1996

Research committees

Lung Cancer

Publication Information Expand/Collapse

1999

Randomized study of CODE versus alternating CAV/EP for extensive-stage small-cell lung cancer: An intergroup study of the National Cancer Institute of Canada Clinical trials group and the Southwest Oncology Group.

N Murray;RB Livingston;FA Shepherd;K James;B Zee;A Langleben;M Kraut;J Bearden;JW Goodwin;C Grafton;A Turrisi;D Walde;H Croft;J Ottaway;D Gandara Journal of Clinical Oncology 17(8):2300-2308

1997

A randomized study of CODE plus thoracic irradiation versus alternating CAV/EP for extensive stage small cell lung cancer

N Murray;R Livingston;F Shepherd;K James;B Zee;A Langleben;M Kraut;J Bearden;J Goodwin;C Grafton;A Turrisi;D Walde;H Croft;J Ottaway Proc of the American Society of Clinical Oncology 16:456a(#1638)

1996

Pilot study of cisplatin, doxorubicin, vincristine and etoposide (PAVE) in elderly and frail patients with small cell lung cancer (SCLC).

V Westeel;N Murray;K Gelmon;M McKenzie;F Wong;J Morris;C Grafton;A Shah;V Tsang;K Goddard;K Murphy;B Sheehan;C. Parsons;R Amy;R Page Proc of the American Society of Clinical Oncology 15(#1125):377

Other Clinical Trials

SWOG Clinical Trial Number
S2302

PRAGMATICA - LUNG: A PROSPECTIVE RANDOMIZED STUDY OF RAMUCIRUMAB (LY3009806; NSC 749128) PLUS PEMBROLIZUMAB (MK-3475; NSC 776864) VERSUS STANDARD OF CARE FOR PARTICIPANTS PREVIOUSLY TREATED WITH IMMUNOTHERAPY FOR STAGE IV OR RECURRENT NON-SMALL CELL LUNG CANCER
Research Committee(s)
Lung Cancer
Activated
03/06/2023
Accrual
85%
Open
Phase
SWOG Clinical Trial Number
A082002

A Randomized Phase II/III Trial of Modern Immunotherapy Based Systemic Therapy with or Without SBRT for PD-L1-Negative, Advanced Non-Small Cell Lung Cancer
Research Committee(s)
Lung Cancer
Activated
12/21/2021
Open
Phase
SWOG Clinical Trial Number
CTSU/NRG-LU007

RAndomized Phase II/III Trial Of Consolidation Radiation + Immunotherapy for ES-SCLC: RAPTOR Trial
Research Committee(s)
Lung Cancer
Activated
08/17/2020
Open